Breaking news today: “Two pharmaceutical subsidiaries of Johnson & Johnson will pay more than $81 million and plead guilty to a misdemeanor charge in a U.S. Justice Department case about illegal promotion of the epilepsy drug Topamax, federal officials announced.”
Let’s reread that one, break it down and let it sink in. The U.S. Justice Department has one misdemeanor case against Ortho-McNeil Neurologics and Noramco. The complaint is illegal promotion of a drug most people haven’t ever heard of. The promoting of a drug which has already been released as generic should cost Johnson & Johnson (the manufacturer’s parent company) 81 MILLION dollars in fines?
This isn’t a drug that has caused deaths. It’s not even inherently responsible for injuries. The drug isn’t the issue. The means of promoting it is. And that earns the Feds 81 MILLION dollars?